Total vial cost divided by the number of doses per vial equals cost per injection
6.2 Novo Nordisk + Septerna (May 2025, up to $2.2B) Novo's second major triple-agonist transaction was a broader small-molecule GPCR collaboration with Septerna announced May 2025: up to $2.2 billion total deal value, $200 million+ upfront, covering four oral small-molecule GPCR programs
The label does not describe or approve maintenance below 1.7 mg (FDA Wegovy label)
Additionally, vitamin C supports the absorption of glutathione in the digestive tract, making it an ideal companion supplement
Yes, rare cases have been reported
With most major insurance carriers increasingly covering FDA-approved weight loss drugs, including plans from Medicaid, Aetna, Blue Cross Blue Shield, UnitedHealthcare, Cigna, and Medicare, understanding your coverage possibilities has never been easier